Menu
Menu
Helen M. Torok, MD, Trillium Creek Dermatology, Medina, Ohio Disclosure: Dr. Torok was an investigator in the Medicis-sponsored Solodyn Phase 2 and 3 studies. Medicis, a division of Valeant Pharmaceuticals,
Gary Goldenberg, MD, Icahn School of Medicine at Mount Sinai, Department of Dermatology, New York, New York; Adam J. Luber, BA, Icahn School of Medicine at Mount Sinai, Department of
William Kirby, DO, FAOCD, Dr. Tattoff, Inc., Beverly Hills, California; Cynthia L. Chen, DO, McLaren Oakland, Pontiac, Michigan; Alpesh Desai, DO, FAOCD, Dr. Tattoff, Inc., Dallas, Texas; Tejas Desai, DO,
Matthias Imhof, MD; Ulrich Kuhne, MD Aesthetic Dermatology Department, Medico Palais Bad Soden, Bad Soden, Germany Disclosure: Drs. Imhof and Kuhne are speakers and advisors for Merz and have received
Philip R. Cohen, MD The University of Houston Health Center, University of Houston, Houston, Texas; The Division of Dermatology, University of California San Diego, San Diego, California; The Department of
Jason Emer, MD; Adam Luber, BA; Jaime Gropper; Harleen Sidhu, MD; Robert Phelps, MD The authors are from Mount Sinai School of Medicine, Departments of Dermatology and Dermatopathology, New York,
